|
Hypertrophy
Citations 171-180 of 683 total displayed.
|
Past content
(since Mar 1999):
|
- Scientific Contributions
Suppression of Cardiomyocyte Hypertrophy by Inhibition of the Ubiquitin-Proteasome System
- Silke Meiners, Henryk Dreger, Mandy Fechner, Sven Bieler, Wim Rother, Christoph Günther, Gert Baumann, Verena Stangl, and Karl Stangl
Hypertension published December 17, 2007, doi:10.1161/HYPERTENSIONAHA.107.097816
[Abstract]
- Scientific Contributions
Activity-Adjusted 24-Hour Ambulatory Blood Pressure and Cardiac Remodeling in Children with Sleep Disordered Breathing
- Raouf Amin, Virend K. Somers, Keith McConnell, Paul Willging, Charles Myer, Marc Sherman, Gary McPhail, Ashley Morgenthal, Matthew Fenchel, Judy Bean, Thomas Kimball, and Stephen Daniels
Hypertension published December 10, 2007, doi:10.1161/HYPERTENSIONAHA.107.099762
[Abstract]
- Editorial Commentaries
LA419, a Novel Nitric Oxide Donor, Prevents Cardiac Remodeling Via the Endothelial Nitric Oxide Synthase Pathway: NO Donors as a Means of Antiremodeling
- Ludovit Paulis and Fedor Simko
Hypertension 2007;50:1009-1011; published online before print as doi:10.1161/HYPERTENSIONAHA.107.100032
[Full text]
- Original Articles
Prevalence and Correlates of Left Ventricular Hypertrophy in the African American Study of Kidney Disease Cohort Study
- Gail E. Peterson, Tine de Backer, Avril Gabriel, Vladimir Ilic, Tudor Vagaonescu, Lawrence J. Appel, Gabriel Contreras, Cindy Kendrick, Stephen Rostand, Robert A. Phillips for the African American Study of Kidney Disease Investigators
Hypertension 2007;50:1033-1039; published online before print as doi:10.1161/HYPERTENSIONAHA.107.090613
[Abstract]
[Full text]
- Original Articles
Synergetic Antioxidant and Vasodilatory Action of Carbon Monoxide in Angiotensin II–Induced Cardiac Hypertrophy
- Atsushi Kobayashi, Kazunobu Ishikawa, Hayato Matsumoto, Satoshi Kimura, Yoshiyuki Kamiyama, and Yukio Maruyama
Hypertension 2007;50:1040-1048; published online before print as doi:10.1161/HYPERTENSIONAHA.107.097006
[Abstract]
[Full text]
- Original Articles
LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation
- Gema Ruiz-Hurtado, María Fernández-Velasco, Marisabel Mourelle, and Carmen Delgado
Hypertension 2007;50:1049-1056; published online before print as doi:10.1161/HYPERTENSIONAHA.107.093666
[Abstract]
[Full text]
- Hypothesis
Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload–Induced Left Ventricular Hypertrophy and Dysfunction
- Zhongbing Lu, Xin Xu, Xinli Hu, Guangshuo Zhu, Ping Zhang, Elza D. van Deel, Joel P. French, John T. Fassett, Tim D. Oury, Robert J. Bache, and Yingjie Chen
Hypertension published November 12, 2007, doi:10.1161/HYPERTENSIONAHA.107.098186
[Abstract]
- Editorial Commentary
LA419, a Novel Nitric Oxide Donor, Prevents Cardiac Remodeling Via the Endothelial Nitric Oxide Synthase Pathway NO Donors as a Means of Antiremodeling
- Ludovit Paulis and Fedor Simko
Hypertension published November 5, 2007, doi:10.1161/HYPERTENSIONAHA.107.100032
[Abstract]
- Scientific Contributions
LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation
- Gema Ruiz-Hurtado, María Fernández-Velasco, Marisabel Mourelle, and Carmen Delgado
Hypertension published November 5, 2007, doi:10.1161/HYPERTENSIONAHA.107.093666
[Abstract]
- Editorial Commentaries
Will the Lessons From Primary Aldosteronism Change the Treatment of Hypertension and Left Ventricular Hypertrophy?
- Richard J. Auchus and Mark H. Drazner
Hypertension 2007;50:837-839; published online before print as doi:10.1161/HYPERTENSIONAHA.107.097303
[Full text]
|
|
